The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …

Until either efficacious therapy or vaccination for COVID-19 is achieved, there will be a need
to regain world economic stability while yet controlling the pandemic with current …

The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Abstract Severe coronavirus disease 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is characterized by an unpredictable …

SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …

The systematic review focused on the prognosis, mortality, medications, and promising
vaccines for COVID-19. COVID-19 severity varies. Mild cases often recover within two …

Introduction Therapy of coronavirus disease 2019 (COVID-19) involves evolving algorithms
that include drugs aimed at reducing disease progression by counteracting two different, but …

Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …

Objectives Rapid review to determine the magnitude of association between potential risk
factors and severity of COVID-19, to inform vaccine prioritisation in Canada. Setting Ovid …

The emergence and rapid spread of SARS-CoV-2 in December 2019 has brought the world
to a standstill. While less pathogenic than the 2002–2003 SARS-CoV, this novel …